Effect of desipramine on patients with breathing disorders in RETT syndrome

OBJECTIVE: Rett Syndrome (RTT) is a severe neurodevelopmental condition with breathing disorders, affecting around one in 10,000 female births. Desipramine, a noradrenaline reuptake inhibitor, reduced the number of apneas in Mecp2‐deficient mice, a model of RTT. We planned a phase 2 trial to test it...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Clin Transl Neurol
Glavni autori: Mancini, Josette, Dubus, Jean‐Christophe, Jouve, Elisabeth, Roux, Jean‐Christophe, Franco, Patricia, Lagrue, Emmanuelle, Castelnau, Pierre, Cances, Claude, Chaix, Yves, Rougeot‐Jung, Christelle, Cornu, Catherine, Desportes, Vincent, Vallée, Louis, Bahi‐Buisson, Nadia, Truillet, Romain, Attolini, Laurence, Villard, Laurent, Blin, Olivier, Micallef, Joëlle
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817841/
https://ncbi.nlm.nih.gov/pubmed/29468173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.468
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items